Overview

Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.

Status:
Terminated
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
To test whether POL7080 is effective in patients with exacerbation of non-cystic fibrosis bronchiectasis caused by Pseudomonas aeruginosa infection.
Phase:
Phase 2
Details
Lead Sponsor:
Polyphor Ltd.
Treatments:
Murepavadin